Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)

Cell‐based therapies hold promise to substantially curb complications from extreme preterm birth, the main cause of death in children below the age of 5 years. Exciting preclinical studies in experimental neonatal lung injury have provided the impetus for the initiation of early phase clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Thébaud, Bernard, Lalu, Manoj, Renesme, Laurent, van Katwyk, Sasha, Presseau, Justin, Thavorn, Kednapa, Cobey, Kelly D., Hutton, Brian, Moher, David, Soll, Roger F., Fergusson, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235145/
https://www.ncbi.nlm.nih.gov/pubmed/33570257
http://dx.doi.org/10.1002/sctm.20-0508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235145/
https://www.ncbi.nlm.nih.gov/pubmed/33570257
http://dx.doi.org/10.1002/sctm.20-0508

Ejemplares similares